Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2015 08/27/2015 08/28/2015 08/31/2015 09/01/2015 Date
535.47(c) 538(c) 536.7(c) 513.5(c) 496.42(c) Last
1 064 486 759 468 507 771 835 294 899 200 Volume
+7.30% +0.47% -0.24% -4.32% -3.33% Change
More quotes
Financials ($)
Sales 2015 4 039 M
EBIT 2015 1 695 M
Net income 2015 674 M
Finance 2015 1 792 M
Yield 2015 -
Sales 2016 4 837 M
EBIT 2016 2 166 M
Net income 2016 1 013 M
Finance 2016 3 163 M
Yield 2016 -
PER 2015 86,48
PER 2016 59,32
EV / Sales 2015 12,3x
EV / Sales 2016 9,99x
Capitalization 51 473 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
08/31 REGENERON PHARMACEUTICALS : Announces Upcoming 2015 Investor Conference Presenta..
08/28 SANOFI : and Regeneron Get FDA Approval of Praluent (alirocumab) Injection
08/27DJFDA Approves Amgen's Cholesterol-Lowering Drug Repatha -- Update
08/27DJFDA Approves Amgen's Cholesterol Drug
08/27DJFDA Approves Amgen's Repatha Cholesterol Drug
08/27 REGENERON PHARMACEUTICALS : Study Data from Regeneron Pharmaceuticals Inc. Updat..
08/27 REGENERON PHARMACEUTICALS : Assigned Patent
08/24 BIOMED REALTY : Regeneron Pharmaceuticals Signs 116,200 SF Expansion With BioMed..
More news
Sector news : Pharmaceuticals - NEC
04:46a AMGEN : Novartis, Amgen partner on Alzheimer's, migraine treatment
04:46a NOVARTIS : Swiss drug maker Novartis, US-based Amgen partner on Alzheimer's, mig..
04:13a FTSE edges higher, buoyed by Ashtead and pharma
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
09/01 Regeneron and Sanofi announce pooled data that show Praluent's cholesterol-lo..
08/31 BIOTECH REVIEW (PART 2 OF 3) : New Coverage Of Some Mid-Caps With Update On Inte..
08/31 Approval Of Repatha May Give Amgen A $5B Boost.
08/31 Alnylam and The Medicines Co's long-acting cholesterol fighter comparable to ..
08/28 PREMARKET BIOTECH DIGEST : Geron EDP Today, Repatha Approval, Mylan Perrigo Deal


Comments 
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions